Cargando…

Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Mueller, B U, Pabst, T, Hauser, P, Gilliland, G, Neuberg, D, Tenen, D G
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360672/ http://dx.doi.org/10.1038/sj.bjc.6603264

Ejemplares similares

Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia
por: Mueller, B U, et al.
Publicado: (2006)

Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism
por: Beesley, A H, et al.
Publicado: (2010)

Recurrent histone mutations in T‐cell acute lymphoblastic leukaemia
por: Collord, Grace, et al.
Publicado: (2018)

Effect of Aplidin in acute lymphoblastic leukaemia cells
por: Erba, E, et al.
Publicado: (2003)

Aberrant splicing in B-cell acute lymphoblastic leukemia
por: Black, Kathryn L, et al.
Publicado: (2019)

Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia
por: Zhu, Y-M, et al.
Publicado: (1999)

Magnetic field exposure and long-term survival among children with leukaemia
por: Foliart, D E, et al.
Publicado: (2006)

Genome-scale definition of the transcriptional programme associated with compromised PU.1 activity in acute myeloid leukaemia
por: Sive, J I, et al.
Publicado: (2016)

Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]
Publicado: (2013)

Seasonality in the diagnosis of childhood acute lymphoblastic leukaemia.
por: Thorne, R., et al.
Publicado: (1998)

Cytotoxicity of tamoxifen for acute lymphoblastic leukaemia in vitro.
por: Blatt, J., et al.
Publicado: (1984)

Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis
por: Liu, T, et al.
Publicado: (2014)

Inotuzumab ozogamicin for acute lymphoblastic leukaemia
Publicado: (2019)

Targeted Therapy in Acute Lymphoblastic Leukaemia
por: Salvaris, Ross, et al.
Publicado: (2021)

Impact of microRNA-29b on nature killer cell in T-cell acute lymphoblastic leukemia
por: Jin, Fengyan, et al.
Publicado: (2021)

Hypereosinophilia: A rare presentation of acute lymphoblastic leukaemia
por: Narayanan, G, et al.
Publicado: (2018)

Preferential transcription of the mutated allele in NPM1 mutated acute myeloid leukaemia
por: Bailey, G. D., et al.
Publicado: (2020)

PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development
por: Zhao, Xinhui, et al.
Publicado: (2022)

Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA
por: Groves, F D, et al.
Publicado: (1999)

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum]
Publicado: (2021)

Reciprocal Roles for CCAAT/Enhancer Binding Protein (C/EBP) and PU.1 Transcription Factors in Langerhans Cell Commitment
por: Iwama, Atsushi, et al.
Publicado: (2002)

Residential mobility and risk of childhood acute lymphoblastic leukaemia: an ecological study
por: Adelman, A S, et al.
Publicado: (2007)

Breastfeeding patterns and risk of childhood acute lymphoblastic leukaemia
por: Kwan, M L, et al.
Publicado: (2005)

Corrigendum to: Re-evaluation of the nor mutation and the role of the NAC-NOR transcription factor in tomato fruit ripening
por: Gao, Ying, et al.
Publicado: (2020)

Higher risk for acute childhood lymphoblastic leukaemia in Swedish population centres 1973-94
por: Hjalmars, U, et al.
Publicado: (1999)

An examination, with a meta-analysis, of studies of childhood leukaemia in relation to population mixing
por: Kinlen, L J
Publicado: (2013)

CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL)
por: Vorwerk, P, et al.
Publicado: (2000)

Computer-Aided Diagnosis of Acute Lymphoblastic Leukaemia
por: Shafique, Sarmad, et al.
Publicado: (2018)

Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
por: Heo, Young-A., et al.
Publicado: (2019)

B-Cell Acute Lymphoblastic Leukaemia of the Uterus
por: Vanheule, Eva, et al.
Publicado: (2020)

Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum]
Publicado: (2018)

BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours
por: D'Arcy, V, et al.
Publicado: (2008)

Therapy-related Acute Lymphoblastic Leukaemia has a Unique Genetic Profile Compared to De Novo Acute Lymphoblastic Leukaemia
por: Kook, Hye Won, et al.
Publicado: (2022)

Corrigendum to “Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features”
por: Khan, Abdullah M., et al.
Publicado: (2019)

Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia
por: Pal, D, et al.
Publicado: (2016)

Factors affecting survival in White and Asian children with acute lymphoblastic leukaemia
por: Powell, J E, et al.
Publicado: (2000)

Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia
por: Schardt, Julian A, et al.
Publicado: (2010)

Adenovirus DNA in Guthrie cards from children who develop acute lymphoblastic leukaemia (ALL)
por: Honkaniemi, E, et al.
Publicado: (2010)

Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia
por: Roman-Gomez, J, et al.
Publicado: (2004)

Corrigendum to “Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System”
por: Banjar, Haneen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q2nesa4sco0m5vkjuai62t1roi